文献速递头颈儿科影像US

基于美国放射学会甲状腺影像报告和数据系统(TI-RADS)调整19岁以下患者甲状腺结节活检大小截断值

Modification of size cutoff for biopsy based on the American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) for thyroid nodules in patients younger than 19 years.
PubMed 文献 · Eur Radiol · 2023-06-30

本研究回顾性纳入两家转诊中心2005年5月至2022年8月19岁以下甲状腺结节患者,以细胞学或手术病理为参考,在训练队列和验证队列中比较ACR TI-RADS指南与新标准(TR3≥35 mm、TR5无阈值)的诊断性能。新标准识别恶性结节的AUC更高,不必要活检率和漏诊恶性率均低于TI-RADS指南。

要点

  • 19岁以下患者新标准(TR3≥35 mm、TR5无阈值)AUC高于TI-RADS指南(训练队列0.809 vs 0.681,验证队列0.819 vs 0.683)。
  • 新标准不必要活检率低于TI-RADS指南(训练队列45.0% vs 56.8%,验证队列42.2% vs 56.8%)。
  • 新标准漏诊恶性率低于TI-RADS指南(训练队列5.7% vs 18.6%,验证队列9.2% vs 21.5%)。

核心结论

  • 基于ACR TI-RADS调整的新标准(TR3≥35 mm、TR5无阈值)可能有助于提高19岁以下患者甲状腺结节的诊断性能,并降低不必要活检率和漏诊恶性率。

研究设计与样本

  • 回顾性研究,从两家转诊中心2005年5月至2022年8月纳入19岁以下有细胞学或手术病理结果的患者,一家中心为训练队列(204例患者、236个结节),另一家为验证队列(190例患者、225个结节)。

诊断标准与关键数值

  • 新标准为TR3≥35 mm、TR5无阈值;训练队列AUC新标准0.809 vs TI-RADS指南0.681(p < 0.001),验证队列AUC新标准0.819 vs TI-RADS指南0.683(p < 0.001)。

临床应用与阅片要点

  • 作者认为新标准(TR3≥35 mm、TR5无阈值)基于ACR TI-RADS用于指示19岁以下患者甲状腺结节细针穿刺,可能有助于提高诊断性能并降低不必要活检率和漏诊恶性率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To modify the size cutoff for biopsy for thyroid nodules in patients < 19 years based on the American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) and evaluate the performance of the new criteria in two referral centers.

METHODS: Patients < 19 years with cytopathologic or surgical pathology results were retrospectively identified from two centers from May 2005 to August 2022. Patients from one center were classified as the training cohort, and those from the other center were classified as the validation cohort. The diagnostic performance, unnecessary biopsy rates, and missed malignancy rates of the TI-RADS guideline, and the new criteria (≥ 35 mm for TR3 and no threshold for TR5) were compared.

RESULTS: A total of 236 nodules from 204 patients in the training cohort and 225 nodules from 190 patients in the validation cohort were analyzed. The area under the receiver operating characteristic curve of the new criteria in identifying thyroid malignant nodules was higher (0.809 vs. 0.681, p < 0.001; 0.819 vs. 0.683, p < 0.001), and the unnecessary biopsy rates (45.0% vs. 56.8%; 42.2% vs. 56.8%) and missed malignancy rates (5.7% vs. 18.6%; 9.2% vs. 21.5%) were lower than that of the TI-RADS guideline in the training cohort and validation cohort, respectively.

CONCLUSIONS: The new criteria (≥ 35 mm for TR3 and no threshold for TR5) for biopsy based on the TI-RADS may help improve the diagnostic performance and reduce unnecessary biopsy rates and missed malignancy rates for thyroid nodules in patients < 19 years.

CLINICAL RELEVANCE STATEMENT: The study developed and validated the new criteria (≥ 35 mm for TR3 and no threshold for TR5) to indicate FNA based on the ACR TI-RADS of thyroid nodules in patients younger than 19 years.

KEY POINTS: •The AUC of the new criteria (≥ 35 mm for TR3 and no threshold for TR5) in identifying thyroid malignant nodules was higher than that of the TI-RADS guideline (0.809 vs. 0.681) in patients < 19 years. •The unnecessary biopsy rates and missed malignancy rates of the new criteria (≥ 35 mm for TR3 and no threshold for TR5) in identifying thyroid malignant nodules were lower than that of the TI-RADS guideline in patients < 19 years (45.0% vs. 56.8% and 5.7% vs. 18.6%, respectively).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Huang, Liu, Zheng, et al. Modification of size cutoff for biopsy based on the American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) for thyroid nodules in patients younger than 19 years. Eur Radiol. 2023. PMID: 37389607. doi:10.1007/s00330-023-09867-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。